Prostate Cancer Screening Among Men With High Risk Genetic Predisposition

Study ID
NCT02053805

Study type
Interventional

Study phase
N/A

Study status
Unknown status

Trial Acronym

Trial Summary

This will be a prospective diagnostic trial of screening for prostate cancer among men with genetic predisposition.

More informations

Trial Starting Date

Feb 28,2014

Requirements

Gender Male
Minimum age 40 Years
Maximum age 70 Years

Enrollement Limit

200

In order to facilitate the use of our website, we use cookies.